A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.

ABSTRACT:

Importance

Gallbladder cancer is uncommon but highly fatal. Surgery remains the only potentially curative treatment for localized or locoregionally advanced gallbladder cancer. The rate of use of neoadjuvant and adjuvant chemotherapy in resectable gallbladder cancer is unknown.

Objective

To assess factors associated with the use of neoadjuvant and adjuvant chemotherapy in patients with resectable gallbladder cancer and survival outcomes.

Design, setting, and participants

The National Cancer Database was used to identify 6391 adults who underwent definitive surgical resection for gallbladder cancers between January 1, 2004, and January 1, 2016. Data analysis was performed from January 15 to February 15, 2020. Patients with localized or locoregionally advanced gallbladd

SUBMITTER: Ozer M 

PROVIDER: S-EPMC8851300 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature